Renée de Mutsert

Renée de Mutsert

Auto-generated profile, based on publicly available information

Renée de Mutsert

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
PDF file
RMRenée de Mutsert
Renée de Mutsert
DGDiana C. Grootendorst
Diana C. Grootendorst
FIFleur Indemans
Fleur Indemans
EBElisabeth W. Boeschoten
Elisabeth W. Boeschoten
RKRaymond T. Krediet
Raymond T. Krediet
FDFriedo W. Dekker
Friedo W. Dekker

11 April 2013 in European Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
RMRenée de Mutsert
Renée de Mutsert
MHMartin Den Heijer
Martin Den Heijer
Ton RabelinkTon Rabelink
Ton Rabelink
JSJohannes Willem Adriaan Smit
Johannes Willem Adriaan Smit
JRJohannes Anthonius Romijn
Johannes Anthonius Romijn
FRFrits Richard Rosendaal
Frits Richard Rosendaal

1 March 2009 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
RMRenée De Mutsert
Renée De Mutsert
DGDiana C Grootendorst
Diana C Grootendorst
EBElisabeth W Boeschoten
Elisabeth W Boeschoten
HBHans Brandts
Hans Brandts
JMJeannette G Van Manen
Jeannette G Van Manen
NGNetherlands Cooperative Study on the Adequacy of Dialysis-2 Study Group
Netherlands Cooperative Study on the Adequacy of Dialysis-2 Study Group
Background: The subjective global assessment of nutritional status (SGA) is used to assess the nutritional status of chronic dialysis patients, but l

30 April 2014 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
RMRenée De Mutsert
Renée De Mutsert
QSQi Sun
Qi Sun
WWWalter C Willett
Walter C Willett
FHFrank B Hu
Frank B Hu
RDRob Van Dam
Rob Van Dam
The relative importance of overweight after childhood and excess weight gain during adulthood remains unclear. In 39,909 male participants of the Health Professionals Follow-Up Study who were 40–75 years of age in 1986 and were followed until 2008, we documented 8,755 incident cases of obesity-related chronic diseases (type 2 diabetes mellitus, cardiovascular diseases, and colorectal, renal, pancreatic, and esophageal cancers). We calculated composite and cause-specific hazard ratios using a model that included body mass index (BMI; weight (kg)/height (m)2) at 21 years of age, weight change since age 21 years, smoking, alcohol consumption, and family histories of myocardial infarction, colon cancer, and diabetes. Compared with a BMI at 21 years of 18.5–22.9, the composite hazard ratio for a BMI of 23–24.9 was 1.22 (95% confidence interval (CI): 1.16, 1.29), that for a BMI of 25.0–27.4 was 1.57 (95% CI: 1.48, 1.67), that for a BMI of 27.5–29.9 was 2.40 (95% CI: 2.17, 2.65), and that for a BMI ≥30.0 was 3.15 (95% CI: 2.76, 3.60). The composite hazard ratios for adult weight gain compared with a stable weight were 1.12 (95% CI: 1.03, 1.22) for a gain of 2.5–4.9 kg, 1.41 (95% CI: 1.31, 1.52) for a gain of 5–9.9 kg, 1.72 (95% CI: 1.59, 1.86) for a gain of 10–14.9 kg, and 2.45 (95% CI: 2.27, 2.63) for a gain ≥15 kg. Adiposity in early adulthood and adult weight gain were both associated with marked increases in the risk of major chronic diseases in middle-aged and older men, and these associations were already apparent at modest levels of overweight and weight gain.

3 April 2008 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
RMR. de Mutsert
R. de Mutsert
DGD. C. Grootendorst
D. C. Grootendorst
JAJ. Axelsson
J. Axelsson
EBE. W. Boeschoten
E. W. Boeschoten
RKR. T. Krediet
R. T. Krediet
TGthe NECOSAD Study Group
the NECOSAD Study Group
Protein-energy wasting (PEW), inflammation and cardiovascular diseases (CVD) clearly contribute to the high mortality in chronic dialysis. Our aim was to examine the presence of additive interaction between these three risk factors in their association with long-term mortality in dialysis patients. Patients from a prospective multi-centre cohort study among ESRD patients starting with their first dialysis treatment [the Netherlands Co-operative Study on the Adequacy of Dialysis-2 (NECOSAD-II)] with complete data on these risk factors were included (n = 815, age: 59 +/- 15 years, 60% men, 65% HD). Hazard ratios (HR) were calculated for all-cause mortality in 7 years of follow-up. The presence of interaction between the three risk factors was examined, based on additivity of effects. Of all patients, 10% only suffered from PEW (1-5 on the 7-point subjective global assessment), 11% from inflammation (CRP >/=10 mg/L), 14% from CVD and 22% had any combination of two components. Only 6% of the patients had all three risk factors. Patients with either PEW (HR: 1.6, 95% CI: 1.3-2.0), inflammation (1.6, 1.3-2.0) or CVD (1.7, 1.4-2.1) had an increased mortality risk. In patients with all three risk factors, the crude mortality rate of 45/100 person-years was 16 deaths/100 person-years higher than expected from the addition of the solo effects of PEW, inflammation and CVD. The relative excess risk due to interaction was 2.9 (95% CI: 0.3-5.4), implying additive interaction. After adjustment for age, sex, treatment modality, primary kidney diseases, diabetes and malignancy the HR for patients with all three risk factors was 4.8 (95% CI: 3.2-7.2). The concurrent presence of PEW, inflammation and CVD increased the mortality risk strikingly more than expected, implying that PEW interacts with inflammation and CVD in dialysis patients.

1 September 2018 in Peptides
Verified
Journal Article
Closed access
TCTim Christen
Tim Christen
STStella Trompet
Stella Trompet
RNRaymond Noordam
Raymond Noordam
JKJan B. van Klinken
Jan B. van Klinken
KDKo Willems van Dijk
Ko Willems van Dijk
RMRenée de Mutsert
Renée de Mutsert